Sleep Apnea Devices Market : Global Size, Share, Trends, Growth and Forecast Year ( 2023 – 2032 )

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Sleep apnea, sometimes referred to as sleep apnoea is typically a severe chronic respiratory sleep disorder which causes interruptions in breathing or periods of shallow breathing during deep sleep and which occurs more often than normal. The disruptions usually last for a few seconds to a few minutes and persist quite frequently at night. Because of the squeezing of air that passes the blockage, while breathing, it results in loud snoring and sometimes choking or snorting sound when breathing resumes.

Sleep apnea results in inadequate oxygen supply to the brain and the rest of the body which might lead to critical disorders and problems, if untreated.

Sleep apnea is hard to diagnose and thus devices are required which help in the diagnosis and treatment of sleep apneas more effectively and quickly. The devices range from color altering light bulbs that sync with inner-body clocks to the gadgets that recite brain waves.

The global sleep apnea device market is anticipated to grow at a CAGR of around 7-10 % over the period of next 5 years.


The growth of this market is attributed towards major pertaining factors including; the surging cases of sleep apnea across the globe, the increasing number of undiagnosed sleep apnea patients, the rising awareness about the ill effects of untreated sleep apnea and related co-morbidities among people, the rising demand for efficient and user-friendly sleep apnea devices and the burgeoning number of companies venturing into sleep apnea and oral appliances markets etc.

Additionally, the governments of various regions are seen to be rolling out numerous initiatives for the betterment of people suffering from OSA around the world. They are allowing disability tax credit benefits which are proving to be largely beneficial and is aiding in the growth of demand for sleep apnea devices. For instance, a non-profit organization in the U.S. called as the American Sleep Apnea Association (ASAA) founded in 1990 promotes awareness regarding sleep apnea, aids in the development of treatments for this serious disorder, and advocates for the interests of sleep apnea patients.

Moreover, in the recent years the market has witnessed colossal technological advancements and developments which have aided in the introduction of new and advanced products into the market and the industry. Alongside, the growing investments and research and developments activities in the sleep apnea diagnostic and therapeutic devices by key market players for enhancing treatment rates also have added immensely to the growth of this market. Some notable developments include Hypoglossal Nerve stimulation, Expiratory Positive Airway Pressure (EPAP), the clinically-validated snoring relief band named Smart Sleep, the oral device O2Vent Optima, the GO2SLEEP smart ring which incorporates artificial intelligence etc.

Furthermore, other factors such as the proliferating usage of oral appliances across the globe, the expansion of medical devices, the surging geriatric and obese population and the robust indirect economic impact of untreated sleep apnea in terms of workplace accidents, roadside accidents, lost productivity, and serious health problems etc. further propel the growth of the sleep apnea devices market.

However, factors such as the high cost associated with diagnostic and therapeutic devices, the stringent regulatory scenario for the approval of these devices, the side effects associated with CPAs, the low awareness related to sleep disorders in low- and middle-income countries and the availability of alternative methods for the treatment of sleep apnea hamper the growth of this market.


By Product Type:

  • Therapeutic Devices
    • Positive Airway Pressure Devices
      • Automatic Positive Airway Pressure Devices
      • Continuous Positive Airway Pressure Devices
      • Bilevel Positive Airway Pressure Devices
    • Facial Interfaces
      • Masks
  • Full-Face Masks
  • Nasal Pillow Masks
  • Nasal Masks
    • Cushions
  • Accessories
    • Humidifier Accessories
    • Power Accessories
    • Transportation Accessories
    • Communication Accessories
    • Chin Restraints
    • Other Accessories
  • Oral Appliances
    • Mandibular Advancement Devices
    • Tongue-Retaining Devices
  • Adaptive Servo-Ventilators
  • Oxygen Concentrators
  • Other Therapeutic Devices
  • Diagnostic Devices
    • Polysomnography Devices
      • Clinical PSG Devices
      • Ambulatory PSG Devices
    • Home Sleep Testing Devices
    • Oximeters
      • Fingertip Oximeters
      • Handheld Oximeters
      • Wrist-Worn Oximeters
      • Tabletop Oximeters
    • Actigraphy Systems
    • Sleep Screening Devices
    • Others

By End User:

  • Sleep Laboratories
  • Hospitals
  • Home Care Settings
  • Individuals
  • Dental Clinics
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


The North American region holds the largest share in the sleep apnea devices market followed by Europe and is projected to continue with the trend in the future years as well. The growth in the region could be attributed to factors such as the increasing awareness regarding sleep apnea in the region, the growing patient pool suffering from sleep disorders in the region, the surging presence of well-established market players in the region, the proliferating number of therapeutic tests conducted in the region, the increasing number of government initiatives focused at reducing the healthcare burden associated with sleep apnea and the presence of advanced healthcare system in the region etc. The major contributors in the region include the U.S and Canada.

The Asia Pacific region is the fastest growing regional market for sleep apnea devices and the same is projected to witness massive upsurge in the market share in the upcoming years also. The growth in the region can be attributed to factors such as the increasing prevalence of sleep apnea disorders in this region, the growing number of people receiving treatment of sleep apnea in the region, the rising demand for technologically advanced devices in the region and the surging number of initiatives taken by the government & other private organizations to raise awareness regarding sleep disorders in the region etc. Furthermore, the rising disposable incomes of people and the high rate of obesity due to adoption rate of sedentary lifestyle among people in the region also contribute effectively in the growth of the regional market. The major contributors in the region include India and China.


  • SomnoMed
  • Mitsui Chemicals Inc.
  • Somnetics International Inc.
  • WEINMANN Emergency Medical Technology GmbH + Co. KG
  • 3B Medical Inc.
  • Philips Healthcare
  • Cadwell Laboratories Inc.
  • Oventus Medical
  • Compumedics
  • Löwenstein Medical
  • Panthera Dental
  • Curative Medical Inc.
  • Philips Respironics
  • CareFusion Corporation
  • GE Healthcare
  • ImThera Medical
  • Itamar Medical
  • Aeroflow Inc.
  • A.G Industries Pvt. Ltd.
  • BMC Medical Co. Ltd.
  • Circadiance
  • DeVilbiss Healthcare LLC
  • Fisher & Paykel Healthcare Limited
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Mylan N.V.
  • Pacific Medico Co. Ltd.
  • PMD Device Solutions Ltd.
  • Sleepnet Corporation.
  • CPAP TotalCare Inc.
  • MedTech
  • Consumer Sleep Solution LLC
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Resmed Inc.
  • Braebon Medical Corporation
  • Other Players


  • In October 2020, Itamar Medical Ltd. a prominent medical device and digital health company emphasizing on the diagnosis of sleep apnea and other respiratory sleep disorders, announced that its flagship WatchPAT™300 Home Sleep Apnea Testing (HSAT) device has been granted PMDA approval for use in the Japanese market, effective September 14, 2020.
  • In March 2021, Signifier Medical Technologies, an innovator in the sleep disordered breathing market announced that eXciteOSA, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring received the prestigious GOOD DESIGN® Award in the Medical category. The device was recently approved by the U.S. Food and Drug Administration (FDA), giving millions of sufferers in the U.S. access to this innovative therapy.

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version
Get 10% discount on any market research report of your choice.
  • Publication date: 27th April 2023
  • Base year: 2022
  • Forecast year: 2023-2033
  • Format: PDF, PPT,Word,Excel

- ISO Certified Logo -

-: Our Clients :-

Subscribe to Our Company Updates

* We will not share your personal information with anyone
Go Up